Latest filing published 06 May 2022 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €10k.
Frederick John Munsch appears in our data through filings on Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) shares, published by SEDI. In total, 4 filings cover trades dated from 1 June 2021 to 3 May 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 6 May 2022 came the latest disclosure, a transaction for €10k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations